Skip to main content
Premium Trial:

Request an Annual Quote

Centogene: Michael Motz

Michael Motz has been appointed as chief commercial officer, pharmaceuticals, of German rare disease diagnostics company Centogene, effective June 1. Most recently, he was entrepreneur in residence at BB Pureos Bioventures in Switzerland. Before that, he held leadership positions at various firms, including Lion Bioscience, Altana Pharma, Sandoz, Roche, and Zealand Pharma. Motz holds a PhD in biochemistry from the Max Planck Institute for Evolutionary Anthropology.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.